major
patient
poor
outcom
admit
intens
care
unit
icu
associ
sever
respiratori
distress
syndrom
sever
communityacquir
pneumonia
cap
usual
attribut
bacteri
agent
introduct
broader
diagnost
panel
increas
sensit
improv
diagnosi
respiratori
virus
relev
impact
outcom
icupati
inde
base
recent
report
virus
account
total
infect
patient
admit
icu
sever
respiratori
distress
howev
mani
studi
focus
role
influenza
viru
eg
etiolog
agent
acut
respiratori
failur
respiratori
virus
influenza
human
rhinoviru
hrv
human
parainfluenza
virus
human
respiratori
syncyti
viru
hrsv
human
coronavirus
hcov
routin
investig
respiratori
sampl
icu
patient
role
caus
icu
admiss
might
estim
understand
etiolog
agent
cap
may
improv
treatment
decis
patient
outcom
howev
despit
technolog
advanc
establish
etiolog
caus
pneumonia
remain
challeng
aim
studi
investig
preval
respiratori
virus
patient
admit
icu
lombardi
region
nearli
million
inhabit
seven
consecut
winter
season
lombardi
region
acut
respiratori
failur
sever
pneumonia
acut
respiratori
distress
syndrom
assist
noninvas
mechan
ventil
extracorpor
membran
oxygen
analyz
seven
consecut
winter
season
novemb
april
respiratori
sampl
collect
admiss
icu
follow
standard
protocol
accord
physician
order
sever
respiratori
syndrom
defin
acut
onset
week
respiratori
failur
hypoxemia
po
fio
ratio
mmhg
posit
endexpiratori
pressur
noninvas
cpap
cmh
bilater
opac
chest
imag
respiratori
sampl
sent
molecular
virolog
unit
fondazion
ircc
policlinico
san
matteo
pavia
accord
influenza
region
surveil
prepared
plan
dgr
ix
dec
dgr
jun
local
ethic
committe
approv
requir
studi
conduct
auspic
influenza
region
surveil
prepared
plan
dgr
dec
dgr
jun
respiratori
sampl
test
panel
laboratorydevelop
realtim
rtpcr
realtim
pcr
abl
detect
quantifi
follow
virus
influenza
viru
b
includ
subtyp
determin
hrsv
type
b
hcov
type
hmpv
hrv
cmv
subset
sampl
studi
period
total
male
femal
patient
hospit
icu
sever
respiratori
distress
patient
adult
year
patient
age
year
children
tabl
overal
median
age
year
rang
yr
two
season
overal
median
age
higher
year
one
season
lower
year
major
icu
patient
year
adult
yr
rang
total
patient
seven
season
note
one
season
patient
age
year
frequent
observ
reach
total
patient
analyz
tabl
respiratori
virus
detect
clinic
sampl
lower
respiratori
tract
lrt
broncho
alveolar
lavag
broncho
aspir
cap
episod
respiratori
virus
detect
sampl
upper
respiratori
tract
urt
nasal
swab
nasopharyng
aspir
episod
mean
cap
episod
analyz
yearli
minimum
episod
season
maximum
episod
season
patient
one
respiratori
virus
detect
patient
result
neg
mean
posit
frequenc
broad
differ
season
fig
inde
highest
posit
frequenc
observ
season
lowest
observ
season
fig
singl
viru
infect
observ
patient
least
two
respiratori
virus
identifi
overal
influenza
common
viru
identifi
patient
follow
hrv
hrsv
influenza
b
viru
hcov
cmv
human
metapneumoviru
hmpv
hpiv
detect
studi
period
mix
infect
n
hrv
frequent
detect
viru
follow
hcov
fig
one
season
hrv
frequent
detect
viru
fig
pediatr
patient
n
total
tabl
age
distribut
icupati
includ
studi
accord
season
regard
nine
report
cmv
infect
episod
except
one
patient
preexist
comorbid
risk
factor
three
case
cmv
detect
least
one
respiratori
viru
hrsv
hrv
anoth
six
case
cmv
observ
singl
infect
result
studi
suggest
nearli
half
patient
admit
icu
sever
respiratori
syndrom
posit
least
one
respiratori
viru
data
agreement
report
focus
viral
etiolog
pneumonia
icu
patient
studi
proport
viral
infect
rang
recent
summar
burk
colleagu
high
proport
viral
infect
observ
patient
cap
seri
frequenc
differ
respiratori
virus
assess
patient
hospit
icu
distribut
lombardi
region
million
inhabit
result
underlin
role
virus
sever
respiratori
distress
age
group
fact
sinc
adequ
therapi
influenza
avail
earli
diagnosi
earli
initi
antivir
therapi
may
improv
outcom
adult
pediatr
patient
use
multiplex
molecular
assay
diagnosi
respiratori
virus
icu
patient
increas
proport
viral
infect
detect
howev
major
weak
recent
studi
concern
cap
assess
often
perform
use
urt
sampl
fact
use
urt
sampl
diagnosi
cap
controversi
inde
studi
analyz
pair
urt
lrt
sampl
urt
sampl
often
result
neg
posit
result
observ
lrt
sampl
addit
studi
lrt
sampl
show
higher
proport
viral
infect
compar
studi
analyz
etiolog
cap
use
urt
sampl
high
proport
viral
infect
describ
could
inde
relat
greater
frequenc
lrt
sampl
avail
diagnosi
compar
studi
import
lrt
test
also
highlight
recent
studi
involv
icu
patient
urt
test
fail
detect
case
lrtconfirm
influenza
expect
influenza
common
viru
detect
icupati
hand
somewhat
surpris
second
frequent
detect
viru
rhinoviru
grow
bodi
evid
associ
rhinoviru
lower
respiratori
tract
diseas
adult
children
inde
present
studi
hrv
detect
lrt
sampl
frequenc
similar
observ
influenza
hrsv
find
provid
new
insight
burden
sever
hrv
infect
addit
data
highlight
need
improv
assay
identifi
respiratori
virus
influenza
especi
highrisk
patient
gener
studi
underlin
import
use
molecular
assay
cover
wide
rang
virus
diagnosi
respiratori
infect
patient
cmv
viru
detect
howev
import
cmv
detect
icuadmit
patient
remain
question
especi
absenc
histolog
evid
infect
result
studi
interpret
within
context
limit
frequenc
differ
respiratori
virus
could
bias
role
center
refer
laboratori
diagnosi
confirm
sever
influenzalik
ill
retrospect
natur
studi
limit
abil
fulli
collect
clinic
inform
conclus
viral
infect
present
larg
proport
icuadmit
patient
cap
addit
influenza
rhinoviru
shown
account
signific
number
viral
cap
episod
final
use
lrt
sampl
appear
inform
urt
sampl
correctli
estim
burden
viral
infect
patient
cap
none
declar
work
support
ministero
della
salut
fondazion
ircc
policlinico
san
matteo
ricerca
corrent
grant
tabl
distribut
influenza
hrv
hrsv
infect
accord
sampl
posit
urt
vs
lrt
ethic
approv
local
ethic
committe
approv
requir
studi
conduct
auspic
influenza
region
surveil
prepared
plan
dgr
dec
dgr
jun
investig
carri
follow
rule
declar
helsinki
http
revis
